ELIZABETH BOWMAN: Open Payments
NPI 1285120865 · PIEDMONT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 18 payments from 7 companies in 2025. Trend: 2023 $90 · 2024 $215 · 2025 $442
Food & beverage: $428Education: $15
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Braeburn Inc. | 2 | $50 |
| ABBVIE INC. | 3 | $49 |
| Insulet Corporation | 1 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $17 |
Products named: VIVITROL, CAPLYTA, BRIXADI, VRAYLAR, Omnipod, Dexcom G6 Transmitter, ARISTADA, REXULTI.
Industry payments across MO — which companies pay providers there.
